Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Cancer Genet Cytogenet ; 96(2): 102-5, 1997 Jul 15.
Article in English | MEDLINE | ID: mdl-9216714

ABSTRACT

Chromosome fluorescence in situ hybridization (FISH) analyses were performed on bone marrow cells in 3 adult patients with MDS or AML with a (16;21)(q24;q22) translocation. FISH analyses with AML1 probes at 21q22 proved in all 3 patients splitting of the AML1 gene at a region spanning exons 5 and 6 and the translocation of its 5' segment to distal 16q. Chromosome painting FISH analysis in patient 1 proved the translocation of the distal 21q segment to 16q, but it failed to prove the presumed translocation of the distal 16q segment to 21q, most likely because of its small size.


Subject(s)
Chromosome Aberrations/genetics , Chromosomes, Human, Pair 16 , Chromosomes, Human, Pair 21 , DNA-Binding Proteins , Leukemia, Myeloid, Acute/genetics , Proto-Oncogene Proteins , Transcription Factors/genetics , Adult , Aged , Bone Marrow/pathology , Chromosome Banding , Chromosome Disorders , Core Binding Factor Alpha 2 Subunit , DNA Probes , Female , Humans , In Situ Hybridization, Fluorescence , Male , Middle Aged , Translocation, Genetic
2.
Leukemia ; 11(4): 599-608, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9096702

ABSTRACT

The t(16;21)(p11;q22) translocation is a non-random chromosomal aberration observed in several types of human acute myeloblastic leukemia (AML), whereas the der(16)t(1;16) and chromosome rearrangements at 12q13 are frequently found in solid tumors. A novel cell line YNH-1 was established from peripheral blood cells of a 46-year-old male with AML (M1) carrying t(16;21) and t(1;16) translocations. YNH-1 has been maintained with a doubling time of 82 h for more than 20 months as a granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) dependent line. Morphologically YNH-1 cells were free-floating immature myeloblasts with lobulated nuclei and vacuoles in the cytoplasm. They were positive for myeloperoxidase but negative for alpha-naphthyl butylate esterase and chloroacetate esterase stainings. In surface marker analysis YNH-1 cells were positive for CD13, CD33 and CD34. Chromosomal analysis showed 46, XY, der(16)t(16;21)(p11;q22)t(1;16) (q12;q13), der(21)t(16;21)(p11;q22), der (6)t(6;12)(q13;q13), der(12)t(6;12)(q21;q13). These translocations were confirmed by fluorescence in situ hybridization (FISH) studies with the ERG-YAC clone and chromosome-specific DNA libraries. Both the FUS/ERG and ERG/FUS chimeric transcripts were identified by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. Thus, YNH-1 could be a useful tool for elucidating the pathophysiology and molecular mechanism in AML with t(16;21),t(1;16) and 12q13 translocations.


Subject(s)
Chromosomes, Human, Pair 16 , Chromosomes, Human, Pair 1 , Chromosomes, Human, Pair 21 , Leukemia, Myeloid, Acute/genetics , Translocation, Genetic , Amino Acid Sequence , Granulocyte Colony-Stimulating Factor/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , In Situ Hybridization, Fluorescence , Interleukin-3/pharmacology , Karyotyping , Leukemia, Myeloid, Acute/pathology , Male , Middle Aged , Molecular Sequence Data , Polymerase Chain Reaction , Tumor Cells, Cultured/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...